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Text
Evolutionary biology is ﬁnding new applications in medi-
cine and public health (Williams and Nesse 1991; Stearns
and Koella 2007; Trevathan et al. 2007; Nesse and Stearns
2008; Gluckman et al. 2009; Omenn 2009; Nesse et al.
2010). Many are in well-established areas, such as popula-
tion genetics, infectious disease, and studies of phylogeny
(Stearns and Koella 2007). After decades of development,
these areas have textbooks, journals, training programs,
and professional societies that provide established founda-
tions for formulating and testing hypotheses (Sober 1985;
Hull and Ruse 1998; Stearns and Hoekstra 2000; Alcock
2001; Futuyma 2009).
Trying to understand why natural selection has
left bodies vulnerable to disease is a newer enterprise
(Williams and Nesse 1991; Nesse and Williams 1994;
Stearns and Koella 2007; Trevathan et al. 2007; Gluckman
et al. 2009; Zampieri 2009). Why is the birth canal narrow?
Why hasn’t selection shaped better protection against
streptococcal infections? Why is malaria much more viru-
lent than rhinovirus? Why do we have lower backs so
prone to failure? Why hasn’t selection eliminated genes for
cystic ﬁbrosis? Why is obesity now epidemic? A complete
answer to such questions requires evolutionary as well as
proximate explanations (Tinbergen 1963; Mayr 1983). In
addition to explanations for how the body works, we also
need evolutionary explanations for how it came to be the
way it is. Understanding the evolutionary origins of disease
vulnerability is not a substitute for understanding proxi-
mate causes of disease; they are synergetic explanations
that together can assist in the search for causes and cures.
This area of work in Darwinian medicine involves sub-
stantial, one might even say onerous, challenges. Criteria
for assessing the adaptive signiﬁcance of a trait remain ten-
tative (Dupre ´ 1987; Rose and Lauder 1996; Orzack and
Sober 2001). Evolutionary medicine goes further by seek-
ing explanations not for adaptations, but for apparently
suboptimal traits, that can be viewed as maladaptations
(Nesse and Williams 1994; Crespi 2000; Nesse 2005). Many
researchers are now addressing such questions (Stearns
and Koella 2007; Nesse et al. 2010; Stearns et al. 2010),
and a new textbook emphasizes this aspect of evolutionary
medicine (Gluckman et al. 2009). However, no consensus
exists about how best to formulate and test hypotheses
about traits that leave bodies vulnerable to disease.
Solutions will likely evolve as they have in other areas
of science. Speciﬁc questions are addressed using a variety
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Abstract
Many evolutionary applications in medicine rely on well-established methods,
such as population genetics, phylogenetic analysis, and observing pathogen evo-
lution. Approaches to evolutionary questions about traits that leave bodies vul-
nerable to disease are less well developed. Strategies for formulating questions
and hypotheses remain unsettled, and methods for testing evolutionary hypoth-
eses are unfamiliar to many in medicine. This article uses recent examples to
illustrate successful strategies and some common challenges. Ten questions
arise in the course of considering hypotheses about traits that leave bodies vul-
nerable to disease. Addressing them systematically can help minimize confusion
and errors.
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work are kept, improved, and applied to new problems.
Along the way, philosophers of science offer perspective
and suggestions.
This article does not attempt to offer a shortcut for
that process, and it certainly does not propose a general
solution to the challenges of testing hypotheses about
adaptation. Instead, it reviews strategies that have proved
effective or ineffective for formulating and assessing
hypotheses about traits that leave bodies vulnerable to
disease. Ten questions arise routinely in the process of
assessing such hypotheses. Considering each question sys-
tematically can help to minimize errors. A preliminary
version of these questions has saved many students from
failure and at least one professor from despair (Nesse
2007). They are like a pilot’s checklist for projects in
evolutionary medicine preparing for takeoff.
Attempts to offer general advice about scientiﬁc meth-
ods are easy to ridicule. When Peter Medawar addressed,
‘What is ‘‘The Scientiﬁc Method,’’?’ he began by noting: ‘If
the purpose of scientiﬁc methodology is to prescribe or
expound a system of inquiry or even a code of practice for
scientiﬁc behavior, then scientists seem to be able to get
on very well without it.… Of what other branch of learn-
ing can it be said that it gives its proﬁcients no advantage;
that it need not be taught or, if taught, need not be
learned?’ (Medawar 1969, 8) However, he continues, ‘Of
course, the fact that scientists do not consciously practice
a formal methodology is very poor evidence that no such
methodology exists.’ He then offers a sophisticated per-
spective on the gulf between the enterprise of formulating
hypotheses and that of testing them, concluding that
‘Imaginativeness and a critical temper are both necessary
at all times, but neither is sufﬁcient’ (p 58). Because both
are rarely well developed in the same person, science pro-
gresses by imaginative scientists proposing a variety of
ideas that are winnowed by others with ‘a more critical
cast of mind.’ The creative process is ineffable, so advice
on scientiﬁc methods inevitably emphasizes errors.
Medawar’s observation is particularly germane for
studies in this area of Darwinian medicine. Traits that
leave bodies vulnerable to disease spur the imagination.
Each one is a mystery. Hypothesis formation begins by
imagining how existing traits could be ‘redesigned’, so
they are less likely to cause disease. Some individuals are
resistant to HIV infection, some have no appendix, and
some ﬁght off tuberculosis easily. Why not all of us? Why
didn’t natural selection shape bodies less vulnerable to
diseases? Such questions inspire students to wonderfully
creative explanations, many of which are, unfortunately,
preposterous. Subtle aspects of evolutionary theory are
rarely the problem. Far more often, mistakes arise from
difﬁculty framing the question or from elementary errors.
Table 1 lists four tasks common to all science, and ten
speciﬁc questions that arise in the process of considering
hypotheses about traits that leave the body vulnerable to
disease. Each task offers opportunities for errors some-
what speciﬁc to this area of work.
The ﬁrst task is to specify the object of explanation.
This seems simple enough, but students overwhelmingly
begin by looking for adaptive functions of diseases or rare
alleles. This is usually a mistake; most diseases and rare
alleles are not shaped by selection. An appropriate object
of explanation is more often a shared trait that leaves
almost all members of a species or a subgroup vulnerable
to a disease.
Specifying the kind of explanation also seems simple,
but pitfalls loom. The ﬁrst arises from failure to under-
stand the difference between a proximate and an evolu-
tionary explanation, and the need for both. Another
arises from failure to distinguish evolutionary explana-
tions based on phylogeny from those based on the func-
tional signiﬁcance of a trait.
Giving every possible hypothesis full and fair consider-
ation is a challenge in all science. This can be especially
difﬁcult for evolutionary explanations because some are
intuitively attractive, others are hard to recognize, and
multiple answers can be correct.
Finally, testing evolutionary hypotheses about vulnera-
bility can be challenging. The most appropriate methods
differ, in under-appreciated and fundamental ways, from
those used to test proximate hypotheses.
A list of generic tasks of science offers little guidance
on its own, but it can help to organize the challenges and
questions that arise when framing and assessing speciﬁc
evolutionary hypotheses about vulnerability to disease.
Ten questions arise routinely in the course of such an
inquiry. Addressing them systematically increases the
chances of successful takeoff and landing.
Challenges associated with specifying the object
of explanation (Q1–3)
Upon ﬁrst recognizing that every trait needs an evolution-
ary explanation, the temptation to try to explain diseases
directly is nearly irresistible. Why did natural selection
shape cancer? What are the beneﬁts of aging? What is the
function of the appendix? How do genes that cause
schizophrenia give a selective advantage? Such seemingly
sensible questions are framed incorrectly (Williams and
Nesse 1991). Most diseases are not shaped directly by nat-
ural selection or other evolutionary forces, so they are
not, themselves, appropriate objects for evolutionary
explanation.
Aspects of the body that make it vulnerable to a dis-
ease are an entirely different matter. They require an
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cer work better? What is the evolutionary explanation for
senescence? Why does the appendix persist? Why do
genes that predispose to schizophrenia persist? These are
good questions. Shifting the focus from diseases to traits
that make organisms vulnerable to disease requires a
major change in perspective.
For many in medicine, an even more fundamental shift
is necessary. Most medical research focuses on how bodily
mechanisms work, and how differences among individuals
account for why some become ill. An evolutionary
approach focuses on how bodily mechanisms evolved,
and how traits shared by most members of the species
leave them vulnerable to a disease. The difference
becomes clear only if the object of explanation and kind
of explanation sought are described explicitly.
The ﬁrst challenge is to specify whether the object of
explanation is a trait universal in the species or variation
in a trait (Q1). Attempts to explain universal traits, such
as the narrow birth canal, wisdom teeth, and synthesis of
bilirubin, proceed very differently from attempts to
explain variations in traits, such as skin color, ability to
digest lactose, or vulnerability to malaria.
The second challenge is to ensure that the trait is
something likely to have evolved. This question (Q2)
helps to avoid the confusion that arises from trying to
posit unitary evolutionary explanations for things like war
or liking miso soup. Selection shaped the behavioral traits
that make war possible, but not war itself. Addressing this
question also helps to minimize attempts to explain dis-
eases directly; cancer, atherosclerosis, and obesity are not
universal traits.
Question 3 encourages precise description of the trait
in question. Traits require different approaches depending
on which of six categories they best ﬁt.
Fixed human traits
The ﬁrst and most obvious category is for universal traits
such as the birth canal, the heart’s mitral valve, the
appendix, the adrenal glands, and the curve of the human
spine. These offer relatively deﬁnable targets for evolu-
tionary explanation.
Facultative adaptations
Other universal traits are facultative adaptations such
as the capacities for skin tanning, adaptation to high-
altitude, callus formation, cough, and fever. Natural selec-
tion shaped these protective responses in conjunction
with regulation mechanisms that express them when they
are likely to be useful. The time scale of such responses
can range from instantaneous to a lifetime. Tissue damage
Table 1. Ten questions for evolutionary studies of disease vulnerability.
Task 1: Deﬁne the object of explanation precisely.
Q1. Is the object of explanation a uniform trait in the species, or is
the goal to explain variations in a trait among groups or
individuals?
Q2. Has the object of explanation been inﬂuenced by evolution?
Q3. What kind of trait is the object of explanation?
a. A ﬁxed human trait, such as the narrow birth canal
b. A facultative trait, such as the capacity for sweating
c. Human genes, in the most general sense of the term
d. Pathogen traits, such as the level of virulence
e. Pathogen genes, such as those that confer antibiotic resistance
f. Somatic cell lines, such as those in tumors or the immune
system
Task 2: Specify the kind of explanation sought
Q4. Is the goal to explain the evolution of the trait, or its proximate
mechanisms?
Q5. Is the goal to explain the trait’s phylogeny, or the evolutionary
forces that shaped it?
Task 3: List and consider all viable hypotheses
Q6. Are all viable hypotheses considered and given fair consideration,
or are some hypotheses neglected, while others receive favored
treatment?
Q7. Could different vulnerabilities cause the disease in different
individuals or subgroups?
Q8. What categories of explanation are under consideration?
a. Mismatch of bodies with environments they did not evolve in
b. Co-evolution with pathogens that evolve faster than hosts can
c. Constraints on selection, such as time required, genetic drift,
and mutation
d. Trade-offs, especially costs associated with apparently superior
alternative possible traits
e. Reproductive success at the expense of health
f. Defenses such as fever and pain that cause harm and suffering,
but were shaped by selection because they offer protection in
certain situations
Q9. Could multiple explanations be correct?
Task 4: Describe the methods used to test the hypotheses
Q10. What methods are used to test the hypotheses?
a. Consistency with evolutionary theory
b. Modeling using quantitative methods
c. Comparative methods
i. Comparisons among species
ii. Comparisons among subgroups of a species
iii. Comparisons among individuals who vary in a trait
d. Experimental methods
i. Extirpation or disruption (e.g. studies that knock-out
genes or block fever)
ii. Augmentation (e.g. administration of extra testosterone)
iii. Examining regulation of a facultative trait to see if it
behaves as predicted
iv. Observing evolutionary changes in the lab or the ﬁeld
e. Examining the details of ﬁt between observed form and a
postulated function
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utes. Callus formation and skin tanning take weeks.
Some responses have a longer horizon. When early
experiences shape the long-term developmental trajectory
of an individual, this is usually described as developmen-
tal plasticity (Stearns 1989; West-Eberhard 2003). One
classic example remains inadequately documented; babies
whose spend their earliest months in hot climates have
more sweat glands as adults (Kawahata and Sakamoto
1951). A similar ﬁnding in voles is well established; those
born at the end of summer have thicker coats (Lee et al.
1987). A review of such environmental inﬂuences during
human development emphasizes the important distinc-
tions among developmental disruptions (such as from
folate deﬁciency), immediately adaptive responses (such
as premature birth to escape an infected uterus), and pre-
dictive adaptive responses, such as those that use intra-
uterine cues to adjust behavior and metabolism to
varying environments (Gluckman et al. 2005a,b).
Predictive adaptive responses are an important research
area in evolutionary medicine (Gluckman et al. 2005a,b).
Responses to cues of two kinds have been studied exten-
sively. Mothers exposed to severe stress give birth to off-
spring with increased responses to stress (Meaney et al.
2007). Mothers exposed to limited nutrition give birth to
offspring prone to obesity, hypertension, diabetes, and
atherosclerosis if they grow up in nutritionally rich envi-
ronments (Gluckman et al. 2005a,b; Barker 2007). In each
case, the change is in the direction that would conceivably
increase the ﬁtness of an offspring living in environmental
conditions similar to those experienced by the mother.
Work is ongoing to determine whether these mechanisms
are indeed facultative adaptations. In both cases, explica-
tion of the epigenetic mechanisms that mediate the effects
will likely provide useful guidance, as will data on the
prevalence and ﬁtness effects of nutrition availability dur-
ing pregnancy (Rickard et al. 2010).
Human genes
Human genes are obvious targets for evolutionary expla-
nation, and population genetics offers reliable methods
(Childs 1999; Lewontin et al. 2000). Attention usually
focuses on variations, but ﬁxed or very common genes
deserve attention also. For instance, most vertebrates have
the enzyme uricase, but the hominid line lost the responsi-
ble gene in the Miocene, leaving us with high levels of uric
acid and vulnerability to gout (Varela-Echavarria et al.
1988; Johnson et al. 2010; Keebaugh and Thomas 2010). Is
this because of the antioxidant properties of uric acid, its
effect on blood pressure, some other beneﬁt, costs associ-
ated with the gene, or just chance? The active reabsorption
of uric acid in the kidney suggests some adaptive function,
but a deﬁnitive answer remains elusive (A ´lvarez-Lario and
Macarrn-Vicente 2010). The answer is important, because
it may help to explain the relationship between modern
diets, obesity and atherosclerosis (Johnson et al. 2010). A
proximate view that assumes uric acid is merely a meta-
bolic byproduct neglects the important possibility that
high uric acid levels may also offer ﬁtness advantages.
Genes that give a reproductive advantage can go to ﬁx-
ation even if they harm health. Men would, on average,
live 7 years longer if their metabolism and behavior were
like that of women. Why aren’t they? Competitive ability
increases ﬁtness more for males than females in a polygy-
nous species, while ability to repair tissues increases
ﬁtness relatively more for females. Data from multiple
species, and from diverse human groups across the past
century, support this hypothesis (Kruger and Nesse
2006).
Could genes that make human mood regulation sys-
tems vulnerable to mania have become ﬁxed because they
give selective advantages, separate from mania, that more
than counter-balance the disadvantages of illness experi-
enced by some people? This purely hypothetical example
illustrates the possibility that alleles can improve ﬁtness at
the expense of health. Of course, the focus is usually on
genetic variation and on why individuals with a variant
might have advantages as well as disadvantages; this has
been proposed for manic depressive illness (Wilson 1998).
The textbook exemplar is the sickle cell hemoglobin
allele. Individuals with two copies get sickle cell disease.
Individuals homozygous for ordinary hemoglobin are vul-
nerable to malaria. Heterozygote individuals have
decreased vulnerability to malaria and limited symptoms
of sickle cell disease; their relative ﬁtness advantage
explains the persistence of the sickle cell allele where
malaria is prevalent (Livingstone 1960; Wiesenfeld 1967;
Piel et al. 2010). This explanation is solid, but it is by no
means a generalizable exemplar for evolutionary medi-
cine. The variation is in a single base pair, it is of recent
origin, and almost all other documented examples of
balancing selection have also been shaped by malaria
(Evans and Wellems 2002).
This has not inhibited attempts to propose heterozy-
gote advantage as an explanation for other traits. As the
most common fatal disease caused by a recessive allele,
carried by 4% of European Americans, cystic ﬁbrosis is a
good candidate. While 70% of cases arise from the Delta
F508 allele, 1400 other causal mutations have been identi-
ﬁed (Collins 1992). Heterozygote mice are protected from
dehydration caused by cholera toxin (Bertranpetit and
Calafell 1996), and their intestinal cells are resistant to
penetration by Salmonella typhi (Pier et al. 1998). Does
this explain the high prevalence and diversity of the cystic
ﬁbrosis allele? It does not ﬁt well with epidemiologic data
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death from diarrhea may be less common, but this is
weak counter-evidence. Attempts to understand the prev-
alence of cystic ﬁbrosis illustrate the human tendency to
think of alleles as either normal or abnormal, as if they
were components in a designed machine. Mutation-selec-
tion balance, and mutation vulnerability of the allele, may
account for most of the prevalence of the cystic ﬁbrosis,
with frequencies perhaps increased because of selective
advantages in certain circumstances.
Recessive alleles causing Tay Sachs and other diseases
of sphingolipid metabolism in Askanazi Jews have also
been attractive targets (Zlotogora and Bach 2003), but
deﬁnitive conclusions have been hard to ﬁnd. Analysis of
new genetic evidence shows positive selection in Askanazi
Jews for ability to metabolize alcohol and lactose, but the
frequency of sphingolipid diseases seems better accounted
for by bottleneck effects (Bray et al. 2010). Another
review considers the general difﬁculties of reaching ﬁrm
evolutionary conclusions about the evolutionary signiﬁ-
cance of recessive alleles and the excessive attention asso-
ciated with hypotheses about heterozygote advantage
(Valles 2010). This review also documents the prevalence
of confusion arising from failure to specify the exact
object of explanation, and it provides a useful taxonomy
of evolutionary explanations for alleles that cause disease
(see Table 2).
Such sophisticated analysis is needed and welcome;
however, many mistakes are much more fundamental.
For instance, untenable hypotheses based on naı ¨ve group
selection are published remarkably often. Hypotheses
about Mendelian defects such as color blindness (Yokoy-
ama and Takenaka 2005) are especially likely to rely on
group beneﬁts that are inconsistent with modern evolu-
tionary theory.
The null hypotheses for increased prevalence of a rare
genetic variant in a subpopulation are founder effects and
drift; however, selection effects are being conﬁrmed. Lac-
tase is the best-studied example. Alleles that allow lactose
digestion in adulthood have dramatically different preva-
lence in different geographic areas; nearly absent in Asia,
they are almost uniformly present in northern Europe
(Simoons 1978). Inability of adults to digest lactose is the
ancestral state, so alleles for lactose intolerance should not
be considered defective. New genetic data show mutations
for lactase persistence arising and being selected for
repeatedly (Tishkoff et al. 2006). The story is not, how-
ever, as simple as strong selection increasing frequencies
of lactase alleles in dairying cultures. It now appears that
such cultures in Europe expanded quickly, with a selective
advantage perhaps as high as 20%, so subpopulations
migrated north, carrying along alleles for adult expression
of lactase (Ingram et al. 2009).
Still unaddressed is the question of why lactase synthe-
sis in adults is inhibited in most human populations. Is
the selection force simply the cost of manufacturing an
enzyme that is usually unnecessary? Does the presence of
lactase increase vulnerability to certain pathogens? Does
inability to digest milk prevent older children from com-
peting with younger siblings? Or, does lactase inhibition
arise from drift of a mutation that is neutral in most
populations? These questions have been surprisingly
neglected.
Adaptation to low oxygen pressure at high altitudes
offers another example; ﬁtness-enhancing haplotypes went
from rare to over 80% prevalence in just 4000 years in
Tibetan Highlanders (Simonson et al. 2010; Yi et al.
2010). The responsible gene, EPAS1, inhibits hypoxia-
induced hemoglobin synthesis, and thereby decreases
medical complications at high altitudes. In the Andes, by
contrast, the same environmental challenge has shaped
very different physiologic mechanisms that are similarly
effective (Beall 2007). Strong selection causes changes, but
it is hard to predict what they will be.
Variations at the ApoE locus also have medical rele-
vance; those with the ApoE 4 allele have high risks of
heart disease and Alzheimer’s disease. These variations are
especially appropriate for evolutionary examination given
marked geographic differences in frequency and near-ﬁxa-
tion of Apo-E 4 in our primate ancestors (Finch 2010).
These alleles may give advantages to meat eaters, but the
exact trade-offs remain unclear (Finch and Stanford
2004).
Searches for the adaptive signiﬁcance of speciﬁc alleles
are most fruitful when selection forces are speciﬁc to a
particular geographic area. For instance, the absence of
Duffy antigen makes it harder for Plasmodium falciparum
to enter blood cells, giving a potent ﬁtness advantage
where malaria is prevalent. However, it also seems to
increase vulnerability to other infections and to predis-
pose to more malignant prostate cancer (Shen et al.
2006). Similarly, the rare individuals who lack the CCR5
antigen are also protected against pathogens entering
cells, in this case, HIV, but they are more vulnerable to
other infections, including West Nile Fever (Ahuja and
He 2010). Both examples illustrate trade-offs that help to
prevent thinking of an allele as all good or all bad.
Table 2. Evolutionary explanations for high frequencies of disease-
causing alleles (Valles 2010, 185).
1 Elevated mutation rate
2 Segregation distortion
3 Reproductive compensation
4 Founder effects and genetic drift
5 Heterozygote advantage (overdominance)
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tion for geographic distribution of rare polygenic diseases
illustrate the perils of advocating for one hypothesis with-
out fully considering all possibilities. For instance, the
increased prevalence of Type I diabetes in northern versus
southern Europe has been used to support the hypothesis
that genes predisposing to diabetes were selected for
during the ice age because high levels of glucose protect
against tissue damage from freezing (Moalem et al. 2005).
However, the predisposing genes do not directly increase
glucose levels; they mediate autoimmune reactions that
destroy pancreatic beta cells, leading, in the absence of
exogenous insulin, to early death. Even if not fatal, Type
I diabetes results in extravagant caloric loss via glucose in
the urine. It seems most unlikely that cold conditions in
northern Europe 14 000 year ago selected for genes pre-
disposing to Type I diabetes. Much more likely are drift
and selection driven by infectious agents.
Pathogen traits and genes
Pathogen traits, such as level of virulence, are easier to
study because they evolve fast enough to observe in the
laboratory, or across a few months or years in natural
populations (Anderson and May 1979; Ewald 1995). Like-
wise, the frequency of pathogen genes is a ﬁne object of
explanation because it changes in response to laboratory
manipulations (Lenski 1998). They also lend themselves
well to phylogenetic studies of practical use in tracking
different clones (Manges et al. 2001) and sources of infec-
tion (Dombek et al. 2000), although such analyses can be
problematic (Gordon 2001).
Cell lines undergoing somatic evolution
Evolution occurring in somatic cell lines poses different
challenges and opportunities. These have been studied
mostly in immune cells and tumors, but somatic evolu-
tion has also been recognized in neurons (Edelman 1987).
Diverse applications in cancer are proving important
(Greaves 2000). Tumors can be viewed as ecosystems in
which cells compete for resources, with more successful
cells displacing others, thus changing the genetic signature
of a tumor as it evolves (Merlo et al. 2006). Apoptotic
cell death after telomere shortening protects against can-
cer at a cost of faster aging (Newbold 2002), and apopto-
sis more generally is essential in development, and in
coping with pathogens and stressors (LeGrand 1997).
A signiﬁcant proportion of cancer arises from muta-
tions early in development resulting in mosaicism (Frank
2010), and positive selection in antagonistic co-evolution-
ary processes may account for maintenance of alleles that
confer cancer vulnerability (Crespi and Summers 2006).
Some genetic abnormalities in laboratory-maintained can-
cer cell lines are now recognized to result from the pecu-
liar selection forces acting on cells grown in bottles. The
evolutionary genetics of subpopulations of cells has been
used to understand metastasis (Nguyen and Massague
2007) and to stage cancers. Evolutionary analysis of
cancer cell lines has enormous clinical signiﬁcance.
The above six objects of explanation are not necessarily
all-inclusive; however, specifying the object of explanation
carefully can help prevent mistakes. While an appropriate
object of explanation is always something that can be
inﬂuenced by evolution, this does not necessarily mean
natural selection; mutation, drift and migration need full
consideration.
Challenges associated with specifying the kind of
explanation sought (Questions 4–5)
The distinction between proximate and evolutionary
explanations, and the need for both, is so natural for evo-
lutionary biologists that it is like riding a bicycle. It was
emphasized by Mayr (1983) and others, but most health
professionals have never heard of it. As a result, proxi-
mate explanations are sometimes proposed as alternatives
to evolutionary explanations. For instance, considering
the functions of fever sometimes elicits suggestions that it
can be explained by the actions of cytokines. Considering
the evolutionary reasons for the narrow birth canal may
elicit a suggestion that it results from developmental
mechanisms, as if they are an alternative to explanations
based on the costs and beneﬁts of a larger or smaller
birth canal.
Tinbergen (1963) provides a more detailed foundation
for evolutionary medicine by outlining the four kinds of
questions that must be answered to provide a full biologic
explanation for any trait: mechanism, development, func-
tion, and phylogeny. The ﬁrst two are proximate explana-
tions, the latter two, evolutionary. His profound main
insight, still widely unrecognized, is that answers to all four
questions are essential; they are not competing alternatives,
but complementary components of a full explanation.
Confusion often arises when information about proxi-
mate mechanisms is used to test a proposal about a trait’s
adaptive signiﬁcance. For instance, if fever is a direct
result of higher metabolic rate, this would undermine the
hypothesis that it is a defense against infection. Data
showing that fever results from an increase in the body’s
temperature set-point helps to conﬁrm that it is an adap-
tation (Kluger 1979).
Confusion sometimes arises from failure to recognize
that a full evolutionary explanation has two components,
the phylogeny of the trait and its adaptive signiﬁcance.
Phylogenetic explanations are sometimes framed as if they
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author is trying to argue that apparently maladaptive
aspects of a trait result from phylogenetic inertia (Blom-
berg and Garland 2002). Sometimes this refers to subopti-
mal traits that are similar to those in ancestral species;
the appendix might be an example. Sometimes it refers to
a mismatch between a slow-evolving organism and a
changing environment. It can also refer to genetic,
mechanical, and other constraints that slow or prevent
change in a trait. Wisdom teeth offer a good example. Do
they cause problems for modern humans because they
were previously useful but now are costly? Or, do con-
straints make reducing the number of molars difﬁcult?
Or, is the explanation not a phylogenetic constraint at all,
but a change in the developmental environment, with
smaller jaws resulting from chewing foods softer than our
ancestors ate?
Much interest has attended the ways in which pheno-
types are altered by mechanisms that regulate gene
expression, some of which can be transmitted for several
generations. For instance, in-utero stress imprints genes in
ways that increase fetal cortisol receptors (Zhang and
Meaney 2010). This is an important and interesting
mechanism. Its adaptive signiﬁcance is a separate ques-
tion. Is this mechanism an adaptation, shaped by selec-
tion to adapt individuals to varying environments? Or, it
is an epiphenomenon of some other process?
Challenges associated with considering all
possible explanations (Questions 6–9)
Failing to consider all possible hypotheses (Q7) is a gen-
eral problem in science, one magniﬁed in evolutionary
studies because all the alternatives are rarely obvious and
some may have intrinsic appeal. Questions about the
adaptive signiﬁcance of apparently maladaptive traits
arouse special fascination. For instance, if you had
thought fever, cough, vomiting, and anxiety were prob-
lems, it is a revelation to realize that they are actually
adaptations. Is menstruation also an adaptation? What
about vomiting associated with high pressure in the eye-
ball? How can we tell?
Systematic consideration of all possible hypotheses is
the antidote to contentious general debates about study-
ing adaptations. Vociferous critiques e.g. (Gould and
Lewontin 1979) have left some with the impression that
all attempts to understand the adaptive signiﬁcance of traits
are scientiﬁcally illegitimate. This global generalization is
the equally incorrect ﬂipside of attempts to ﬁnd adaptive
explanations for everything (Reeve and Sherman 1993;
Queller 1995; Alcock 2001). Most physicians and medical
researchers are unfamiliar with the history of these con-
troversies (Ruse 2000; Segerstra ˚le 2000) and the many
attempts to resolve them (Maynard Smith and Holliday
1979; Reeve and Sherman 1993; Rose and Lauder 1996).
This may be just a well; debates about adaptation in gen-
eral offer little help. Progress is coming thanks to studies
of speciﬁc questions that consider every possible hypothe-
sis, one by one, with as much objectivity as humans can
manage. Examples illustrate the beneﬁts of this approach.
Dogs and cats can synthesize vitamin C, so they rarely
get scurvy, but apes have mutations in the gulonolactone
oxidase gene so they cannot synthesize vitamin C. The
accepted evolutionary explanation has been that our
ancestors had plenty of fruit in their diets, so there was
no selection to maintain vitamin C synthesis pathways
(Jukes and King 1975). This is plausible, but it does not
consider the possibility that the mutations offered a selec-
tive advantage, perhaps by reducing reactive oxygen pro-
duction, or by ﬁne tuning stress response regulation via
effects on hypoxia inducible factor 1a, or by noncoding
effects of the gulonolactone oxidase pseudogene (De
Tullio 2010; Johnson et al. 2010). Understanding why
humans cannot synthesize vitamin C could be important
for clinical recommendations.
Vomiting associated with acute angle glaucoma has
been hypothesized to be a speciﬁc adaptation to reduce
salt in the body, thus reducing eyeball pressure (Wood
2008). It would be remarkable if a rare disorder of adult
life could shape such a speciﬁc protective response, espe-
cially one with little likelihood of actually relieving the
condition (Pasca and Nesse 2008). The neglected alterna-
tive hypothesis is that vomiting is an epiphenomenon that
arises from mechanisms that are more general.
The persistence of genes that cause schizophrenia poses
a puzzle many have attempted to solve. Some postulate
selective advantages for schizophrenia itself (Allen and
Sarich 1988), or an advantage to the group (Stevens and
Price 1996). Some propose genetic linkage to a strongly
selected locus (Burns 2005). Some attempt to incorporate
phylogenetic and proximate mechanisms into a uniﬁed
explanation (Horrobin 1998). Others offer a more com-
plex explanation, based on the origins of language and
cerebral asymmetry, that includes aspects of proximate
mechanisms, phylogeny, development, and functional sig-
niﬁcance in a complex mix (Crow 1997). Progress has
been slow, in large part because most of these hypotheses
have been considered in isolation from each other. More
comprehensive approaches are ﬁnally appearing (Polimeni
and Reiss 2003; Bru ¨ne 2004), just in time to take
advantage of new genetic data that will likely answer the
question.
An intriguing recent proposal about schizophrenia
builds on Haig’s work on mechanisms that advance the
competing interests of paternal versus maternal genes
(Haig 1993). The weight of an offspring that maximizes
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the mother; the next child may have a different father, so
calories conserved for a subsequent pregnancy give greater
beneﬁts to maternal than paternal genes. As sperm form,
a process called imprinting turns off some genes that
make offspring smaller. The process of egg formation
turns off genes that tend to make offspring larger. When
these opposing forces balance, all is well, however deﬁ-
cient inﬂuences from either side result in offspring sub-
stantially larger or smaller than normal. This illustrates
the possibility of disease vulnerability arising from com-
petitions that create an arms race between maternal and
paternal genomes.
Genes imprinted during gamete production can also
inﬂuence behaviors that differentially inﬂuence maternal
and paternal ﬁtness. This combines with evidence for
variation in expression of maternally and paternally
imprinted genes in different areas of the brain to suggest
a creative hypothesis (Badcock and Crespi 2006). Gross
imbalance of epigenetic effects that favor the interests of
the mother or the father could help to explain the syn-
dromes of schizophrenia and autism, respectively (Crespi
et al. 2009). The full argument is complex, and relies on
interpreting rapidly increasing new data on imprinted
genes, but it illustrates the heuristic value of an evolution-
ary approach.
The possible adaptive signiﬁcance of menopause has
spurred intense research ever since it was proposed to give
a selective advantage because older women may advance
their genetic interests more by assisting existing children
than by additional direct reproduction with its attendant
risks to a mother and her existing children (Williams
1957). Theoretical models and increasingly sophisticated
data from hunter-gatherer populations have been brought
to bear on this hypothesis, and the related idea that sur-
viving grandmothers increase their grandchildren’s repro-
ductive success (and thus, their own inclusive ﬁtness)
(Rogers 1993; Hawkes 2004; Shanley et al. 2007). This line
of research has implications for understanding other phe-
nomena, including the duration of the human life-span
(Hawkes 2004), even as new data challenge its original for-
mulation (Lahdenpera ¨ et al. 2010). However, menopause
may turn out to be an epiphenomenon of competition
between eggs in the ovary (Reiber 2010), perhaps one that
is also inﬂuenced by grandmother effects.
The appendix offers another instructive example. Is it
just an atavistic remnant? Or is it an adaptation that
stores helpful bacteria to repopulate the gut after it has
been purged by an infection (Bollinger et al. 2007)? Com-
parative data bear on the question, but anatomic studies
suggest that the trait is difﬁcult even to deﬁne with exact-
ness (Fisher 2000). Could the human appendix persist
because individuals with a smaller and thinner appendix
are more vulnerable to appendicitis (Nesse and Williams
1994). It is peculiar to think that appendicitis could be
the selection force that maintains the appendix! I rather
doubt that this will turn out to be correct, but it illus-
trates how the persistence of a trait can conceivably be
explained by the very factors that make it disadvanta-
geous.
Six categories of explanation
Bodies have traits that leave them vulnerable to disease
for six main reasons (Q8). As listed in Table 1, they are
mismatch with the modern environments, co-evolution
with pathogens, trade-offs, constraints on natural selec-
tion, reproductive success at the expense of health, and
protective defenses that are easily confused with diseases
(Nesse and Williams 1994; Nesse 2005). Each deserves
consideration.
They are not, however, mutually exclusive; multiple
factors may contribute to a full explanation (Q9). This
makes this line of evolutionary research very different
from most proximate research. In experimental studies
on mechanisms, evidence for one hypothesis tends to
undermine others; DNA either is a double helix, or it is
not. For evolutionary questions, multiple answers may
be correct. For instance, our vulnerability to atheroscle-
rotic disease arises substantially from exposure to novel
aspects of our modern environment (Eaton et al. 1988),
but is also probably a product of trade-offs between the
advantages of having an immunologically responsive
endothelium and the disadvantages of plaque formation
(Nesse and Weder 2007). Direct infectious causes may
also prove important (Ewald and Cochran 2000).
Genetic differences among human subpopulations may
also play an important role, especially differences in
mitochondrial DNA (Wallace 2005) and ApoE (Finch
and Stanford 2004). These factors interact in complex
causal networks, and the relative importance of each fac-
tor may be different in different populations, or even in
different individuals (Q7). Ignoring such complexities is
a mistake.
When the breadth of the evolutionary medicine is
acknowledged, a narrow focus can be helpful, for
instance, on mismatch (Gluckman and Hanson 2006).
However, some evolutionary approaches to disease
emphasize one of the six factors to the exclusion of oth-
ers. For instance, a book on evolutionary psychiatry
emphasizes the role of novel aspects of modern social
environments (Stevens and Price 1996). The role of novel
environments is certainly important, but other factors are
also. Others approaches emphasize the role of pathogens
and co-evolutionary arms races in shaping vulnerability
to disease (Ewald and Cochran 2000). There is no doubt
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tious causes, but considering one factor separate from
others makes interpretation difﬁcult. Some authors inter-
pret almost all responses as protective defenses. Others,
especially geneticists, interpret most phenomena as arising
from mutation and drift unless strong evidence forces
consideration of other possibilities. It is best, when possi-
ble, to consider multiple explanations in concert.
The appropriate initial tests differ depending on what
kind of explanation is proposed. Testing a proposal about
mismatch begins with a search for evidence that the dis-
order is more common in modern environments and that
it varies in predicted ways with environmental character-
istics. Proposals about co-evolution begin by demonstrat-
ing an infectious cause, or the cost of defenses against
infection. Explanations based on constraints begin by
demonstrating mutation rates, path-dependence, or other
constraints that limit optimality. Hypotheses about trade-
offs consider variations in the trait, observed or hypothet-
ical, and the costs and beneﬁts of deviations from the
observed mean. Proposals about reproductive success at
the expense of health begin by looking for a reproductive
advantage associated with a trait that also causes harm.
Finally, proposals about defenses are assessed by demon-
strating that they are, indeed, protective and that the
mechanisms that regulate their expression respond appro-
priately to cues indicating the presence of the relevant
danger. These methods are only the start of hypothesis
testing, but it is worth recognizing that the initial
approach differs depending on what kind of explanation
is under consideration.
Challenges arising from choosing methods for
testing hypotheses (Q10)
Testing evolutionary hypotheses about disease uses the
same basic principles as the rest of evolutionary biology,
but some of these methods are unfamiliar to many in
medicine. A brief review of several is no substitute for full
descriptions, but it can alert readers to the range of possi-
bilities.
The ﬁrst method is easy and powerful; hypotheses must
be consistent with modern evolutionary theory (Q10a). A
remarkable number of proposed explanations do not
qualify. For instance, a noted researcher recently replied
to an audience member’s question by saying aging was
necessary so the species can evolve faster. Another used
the same explanation for why DNA is vulnerable to
mutations that cause cancer. Errors arising from such
naı ¨ve notions about group selection remain common in
medicine. These errors have nothing to do with sophisti-
cated debates about levels of selection (Dugatkin and
Reeve 1994; Keller 1999).
Hypotheses must also be consistent with plausible
speeds of selection. For instance, genes for nearsighted-
ness are sometimes thought to be prevalent now because
eyeglasses have eliminated their effects on ﬁtness for the
past few hundred years. However, even if nearsightedness
were selectively neutral, drift would not bring it to
a prevalence of over 30% in just a few generations. Epi-
demiologic data conﬁrm the conclusion; high rates of
nearsightedness emerge in a society within one generation
after children are ﬁrst subjected to early schooling (Norn
1997). Relaxed selection is not a viable explanation for
myopia.
Hypotheses based on implausibly slow selection can
also be ruled out. Some researchers assume that human
genomes have not changed in the past 10 000 years; this
is contradicted by new evidence for substantial changes in
human subpopulations. The spread in the last 5000 years
of genes that express lactase in adults is a good example
(Tishkoff et al. 2006), as is evidence for selection acting
in the past 4000 years on alleles that allow adaptation to
high altitudes (Beall 2007). Changes in social structures
over the past few thousand years have also given rise to
potent selection forces (Cochran and Harpending 2009),
as conﬁrmed by evidence that resistance to tuberculosis is
greater in populations that have usually lived in urban
settings (Barnes et al. 2010).
Mathematical models offer another method unfamiliar
to many in medicine. Quantitative descriptions of pro-
posed evolutionary processes have supported and chal-
lenged proposed explanations for phenomena such as
menopause (Rogers 1993) and senescence (Hamilton
1966; Kirkwood and Rose 1991) and extraordinary behav-
iors (Grafen 1991) (Q10b). Mathematical models have
been especially valuable in infectious disease, where they
often correct ﬂawed intuitions (Anderson and May 1979;
Bergstrom et al. 2004).
The comparative method is the gold standard for test-
ing evolutionary hypotheses (Harvey and Pagel 1991)
(Q10c). Comparisons of similarities and differences
among traits can help to establish phylogenetic relation-
ships among species. A related application of the compar-
ative method can address the adaptive signiﬁcance of
traits. The hypothesis that the white coat of arctic hares
and polar bears is an adaptation can be tested by examin-
ing closely related species that do not live in the Arctic.
The hypothesis that higher uric acid levels are selected to
slow oxidative damage in longer-lived species can be
tested by correlating uric acid levels with life-span for
diverse primates (Ames et al. 1981). Cross-species com-
parisons provide important information about traits such
as the appendix (Fisher 2000) and primate diets (Leonard
2007). Specialized methods allow determination of
whether trait similarities arise from exposure to similar
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ships.
Our preoccupation with the woes of a single somewhat
peculiar hominid species limits applications of the com-
parative method in medicine, especially when the trait is
only in humans, such as absence of the enzyme uricase.
However, the comparative method can test hypotheses
about the origins of genetic differences between human
subgroups by mapping environmental variations to allele
frequencies. Studies of lactase (Tishkoff et al. 2006) and
sickle cell disease (Piel et al. 2010) provide exemplars.
Experimental methods (Q10d) can offer powerful tests
for evolutionary hypotheses, but the underlying logic is
somewhat different from that in proximate science.
Instead of varying one factor to observe downstream
changes that illuminate a mechanism, experiments to test
hypotheses about function tend to disrupt or augment a
trait to look for resulting malfunctions and trade-offs.
There is nothing new about the method. Physiologists
have long extirpated organs to investigate their functions.
More recently, gene knockout studies address evolution-
ary questions about the functional signiﬁcance of speciﬁc
genes.
Experimental disruptions are especially effective meth-
ods for studying facultative adaptations. For instance, the
utility of fever can be demonstrated by the slower recov-
ery times of individuals who take an antipyretic during
an infection (Doran et al. 1989; Stephenson 1993; Kluger
et al. 1998). However, lack of obvious detrimental effects
from blocking a defense does not prove it is just an epi-
phenomenon – the body has redundant protective mecha-
nisms. The role of temperature can be distinguished from
other aspects of inﬂammation by studying cold-blooded
animals. Infected lizards crawl closer to a heat source and
increase their body temperature. Those prevented from
doing so are more likely to die, thus demonstrating the
value of increased body temperature (Kluger et al. 1998).
Fever can also be studied by artiﬁcial augmentation
(Q10e ii). The effects of sauna baths on infection offer an
example, and Wagner-Jauregg won the 1927 Nobel Prize
for showing that fever induced by malaria slowed the
progression of otherwise-fatal syphilis (Brown 2000).
Predictions about regulation mechanisms can test
hypotheses about facultative responses. If selection shaped
a response to deal with a certain situation, the regulation
mechanism should express the response to cues that indi-
cate the presence of that situation. Many examples are
too obvious to be interesting. Foreign matter in the respi-
ratory system arouses cough. Overheating sets off sweat-
ing. Other examples deserve more study. For instance, if
vomiting is a protective response to toxins in the gut, it
should be expressed whenever the net beneﬁts are greater
than the net costs. Likewise, if social anxiety is useful to
protect against attack by dominant others, its intensity
should be proportional to the degree of risk present.
Our knowledge about the effects of blocking protective
responses has surprising gaps. This is unfortunate because
so much of medicine consists of using drugs to relieve
symptoms. While every doctor knows the dangers of
blocking cough after surgery, much uncertainly attends
decisions about treatment of everyday diarrhea and
rhinorrhea. Existing studies tend to be purely empirical,
without grounding in an evolutionary approach. Findings
from new experiments that disrupt defensive responses
will have important clinical implications.
Finally, the best test of a hypothesis may be considering
the details of its form in light of its proposed function
(Q10e). The correspondence is sometimes obvious; eyes
were shaped for vision. Only a fool would demand stud-
ies comparing the reproductive success of blind and
sighted hunter-gatherers to determine the function of the
eyes. Human eyebrows are slightly more challenging, but
their form is well-suited to directing sweat to away from
the eyes; the sufferings of those who shave their eyebrows
conﬁrm this function. As is often the case, however, other
functions are also important, in this case, social signaling.
Mapping form to function can also be treacherous,
however. Some have suggested that white hair is an adap-
tation that accurately signals age and high status, but it
seems more likely to be simply an epiphenomenon of
aging melanocytes. Conversely, human female breasts have
been viewed as merely for fat storage, but they also likely
serve signaling functions (Low et al. 1987). Menstruation
is more problematic. It is clearly costly, and many of its
characteristics suggest the plausible hypothesis that it
might clear pathogens from the reproductive tract (Profet
1993). However, physiologic evidence refutes the proposal;
the costs of menstruation are less than those of continual
maintenance of the endometrium, and menstruation is
more likely to increase than decrease the pathogen load in
the reproductive tract (Strassmann 1996).
Global skepticism about explanations that deduce func-
tion from form is common but unjustiﬁed. Each proposal
needs to be assessed on its own merits. The form of a
trait can sometimes rule out a proposed function. For
instance, the proposal that vomiting is an adaptive
response to acute angle glaucoma fails because there is no
evidence that it actually lowers intraocular pressure (Pasca
and Nesse 2008). The proposal that depression is an
adaptation to focus cognition on solving a major problem
is worthy but insufﬁcient (Andrews and Thomson 2009);
low mood aroused by a life problem may be a different
phenomenon from serious clinical depression, many cau-
sal pathways can result in depression, rumination can
sometimes be pathologic, and depressed mood can have
other functions. Nonetheless, the suggestion calls useful
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in certain situations, and it offers a possible, and testable,
explanation for why depression arises so often in difﬁcult
life situations.
Sometimes a simple correspondence of form to func-
tion can be convincing. For instance, about 15% of
human breast milk consists of indigestible complex oligo-
saccharides. This offers a classic evolutionary mystery.
Why waste calories making something a baby cannot
digest? It turns out that pathogenic bacteria cannot make
use of these oligosaccharides, but biﬁdobacteria, major
components of the normal gut ﬂora, can. These indigest-
ible sugars give helpful bacteria a head start (Zivkovic
et al. 2010). This is not conclusive proof, but the match
of form to function is strong. Further support comes
from the timing; synthesis of these oligosaccharides is
highest immediately after birth, then they decline. Such
evidence pushes this hypothesis far ahead of the compet-
ing hypothesis that it is just an epiphenomenon, but work
continues. We will know more after comparing the gut
ﬂora of babies who nurse at the breast to those fed with
sterile breast milk or milk substitutes.
Conclusion
Much of the recent interest in evolutionary applications
in medicine comes from attempts to understand traits
that leave bodies vulnerable to disease. Such questions are
especially fascinating because each is a mystery wanting a
solution. It is not surprising that they inspire creative
hypotheses. However, creativity and criticism need each
other. As Medawar puts it: ‘The most imaginative scien-
tists are by no means the most effective; at their worst,
uncensored, they are cranks. Nor are the most critically
minded. The man notorious for his dismissive criticism,
strenuous in the pursuit of error, is often unproductive,
as if he had scared himself out of his own wits – unless
indeed his critical cast of mind was the consequence
rather than the cause of his infertility’ (Medawar 1969,
58). Darwinian explanations of traits that leave us vulner-
able to disease will ﬂourish and advance medicine to the
extent that they can maintain a balance between the crea-
tive and the critical.
The ten questions posed here are no substitute for
knowledge and experience, just as a pilot’s preﬂight
checklist is no substitute for ﬂight training. Nonetheless,
they may help to prevent confusion and common errors.
Systematically, addressing all ten questions may help
stream creativity into productive channels, thereby estab-
lishing, ‘a dialog between fact and fancy, the actual and
the possible, between what could be true and what is in
fact the case…[Science] begins as a story about a Possible
World – a story which we invent and criticize and modify
as we go along, so that it ends by being, as nearly as we
can make it, a story about real life’ (Medawar 1969, 59).
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